Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Esmeron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,190Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection
    Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection

    18 Dec 2025

    // PRESS RELEASE

    https://www.fresenius-kabi.com/us/news-and-events/first-ever-rocuronium-bromide-injection-stable-at-room-temperatu

    PRESS RELEASE
    18 Dec 2025
    Share Share
    Sterinova’s Rocuronium Bromide Receives Approval in US
    Sterinova’s Rocuronium Bromide Receives Approval in US

    24 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219108

    FDA
    24 Oct 2025
    Share Share
    Enforcement Report - Week of September 6, 2023
    Enforcement Report - Week of September 6, 2023

    06 Sep 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf

    FDA
    06 Sep 2023
    Share Share
    Enforcement Report - Week of August 9, 2023
    Enforcement Report - Week of August 9, 2023

    09 Aug 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf

    FDA
    09 Aug 2023
    Share Share
    GENIXUS Announces Launch of KinetiXTM Rocuronium Bromide Injection
    GENIXUS Announces Launch of KinetiXTM Rocuronium Bromide Injection

    03 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230803139911/en

    BUSINESSWIRE
    03 Aug 2023
    Share Share
    Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection
    Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection

    30 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230530005081/en

    BUSINESSWIRE
    30 May 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.